Brief: Lee's Pharmaceutical Holdings Posts FY Profit Attributable Of HK$125.6 Mln
26/03/2020 09:42
March 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* FY REVENUE HK$1.22 BILLION VERSUS HK$1.14 BILLION
* FY PROFIT ATTRIBUTABLE HK$125.6 MILLION VERSUS HK$418.3
MILLION
* "2020 WILL BE MOST CHALLENGING YEAR THAT GROUP HAS EVER
FACED
BEFORE"
Source text for Eikon: ID:nHKS1qzTz1
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA